Can Severe Hypoglycemia be Eliminated? Introducing Estimated Residual Extracellular Insulin (EREI)
Objective
This retrospective analysis compares incidence of hypoglycemia with and without use of the specialized EndoTool EREI (estimated residual extracellular insulin) adjustment feature.
Setting
Cohort of 84 community hospitals.
Results
- Incidence of hypoglycemia <40 mg/dL was 63% lower when the EndoTool EREI adjustment feature was enabled.
- Specifically, hypoglycemia occurred at a rate of one for every 351 patient days of intravenous insulin therapy with the EREI adjustment feature versus one for every 129 patient days without the EREI adjustment feature.
Conclusions
Use of the specialized EndoTool EREI adjustment feature significantly reduces incidence of hypoglycemia without significantly impacting glycemic control.
Authors
W. Patrick Burgess, PhD, MD; Laura Santana, RN; Laurel Fuqua, RN, MSN.
Source
Presented at Annual Diabetes Technology Meeting. Published in Journal of Diabetes Science and Technology, Volume 1, Issue 2, p373.
Year
2019
Tags
- Cost Savings
- Healthcare-Associated Infections
- Hospital-Acquired Conditions
- Hyperglycemia Reduction
- Hypoglycemia Reduction
- Length of Stay
- Surgical Site Infections
- Glucose Variability
- Mean Glucose Improvement
- Target Goal Attainment
- Time in Range
- Time on IV Insulin
- Time to Target
- Burn Injury
- Cardiac Surgery
- DKA/HHS Management
- Emergency Department
- Induced Hypothermia
- Intra-op Glucose Management
- Obstetrics/Labor & Delivery
- Pediatrics
- Residual Insulin Adjustment
- BG Check Compliance
- BG Test Reduction
- Nursing Satisfaction
- Protocol Adherence
- Provider Satisfaction
- Workflow Improvements